ALYSSA SEBASTIANELLI: Open Payments
NPI 1922554518 · STATE COLLEGE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$498 in 20 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $64 · 2025 $498
Food & beverage: $498
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $153 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $90 |
| ABBVIE INC. | 4 | $87 |
| Ardelyx, Inc. | 2 | $62 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $27 |
| Novo Nordisk Inc | 1 | $22 |
| Regeneron Healthcare Solutions, Inc. | 1 | $20 |
| Ipsen Biopharmaceuticals, Inc | 1 | $20 |
| Phathom Pharmaceuticals, Inc. | 2 | $17 |
Products named: TREMFYA, IBSRELA, XIFAXAN, RINVOQ, SKYRIZI, RELISTOR, ENTYVIO, Wegovy.
Industry payments across PA — which companies pay providers there.
